CalciMedica Announces Publication of Preclinical Data in EMBO Molecular Medicine Supporting the Development of CRAC Channel Inhibitors for Inflammatory Bowel Disease (IBD)
Benzinga,
Study provides further validation of the potentially broad utility for CRAC channel inhibitors in inflammatory diseases Data…